Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma

Endocrine

Volumn 38, Issue 2, 2010, Pages 254-259

  Zhu, Yu ^a   He, Hong Chao ^a   Su, Ting Wei ^b   Wu, Yu Xuan ^a   Wang, Wei Qing ^b   Zhao, Ju Ping ^a   Shen, Zhoujun ^a   Zhang, Chong Yu ^a   Rui, Wen Bin ^a   Zhou, Wen Long ^a   Sun, Fu Kang ^a   Ning, Guang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Pheochromocytoma; Preoperative management; Adrenoceptor antagonist

Indexed keywords

DOXAZOSIN; PHENOXYBENZAMINE;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE REGULATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOCRINE SURGERY; FEMALE; FLUID INTAKE; HEMATOCRIT; HEMODYNAMICS; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA; PREMEDICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

EID: 78149409417     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9381-x     Document Type: Article

References (14)

1. JW Lenders G Eisenhofer M Mannelli K Pacak 2005 Pheochromocytoma Lancet 366 9486 665 675 10.1016/S0140-6736(05)67139-5 16112304 (Pubitemid 41176020)
2. K. Pacak, G. Eisenhofer, H. Ahlman, S.R. Bornstein, A.P. Gimenez-Roqueplo, A.B. Grossman et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat. Clin. Pract. Endocrinal. Metab. 3(2), 92-102 (2007)
3. M. Brown, Pheochromocytoma, in Oxford Textbook of Medicine, 3rd edn., ed. by D.J. Weatherall, J.G.G. Ledingham, D.A. Warrell (Oxford University Press, Oxford, 1996), pp. 2553-2557
4. DL Bogdonoff 2002 Pheochromocytoma: specialist cases that all must be prepared to treat? Cardiothorac. Vasc. Anesth. 16 3 267 269 10.1053/jcan.2002. 124131 (Pubitemid 34701174)
5. Y Miura YoshinagaK Doxazosin 1988 A newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma Am. Heart J. 116 6pt2 1785 1789 1:STN:280:DyaL1M%2FnsVGguw%3D%3D 10.1016/0002-8703(88)90230-X 2904751 (Pubitemid 19015661)
6. C Prys-Roberts JR Farndon 2002 Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma World J. Surg. 26 8 1037 1042 10.1007/s00268-002-6667-z 12192533 (Pubitemid 36920305)
7. DL Pan HZ Li ZP Zeng 2004 The discussion of standards for clinical functional gradation and preoperative preparation of pheochromocytoma Chin. J. Surg. 42 18 1089 1092 15498292
8. Y Zhu WQ Wang YX Wu CY Zhang WB Rui WL Zhou, et al. 2007 Application of doxazosin controlled-release tablets in the pre-operative management of patients with pheochromocytoma: a pilot study J. Mod. Urol. 12 83 84
9. SZ Langer 1981 Presynaptic regulation of the release of catecholamines Pharmacol. Rev. 32 7 337 362
10. LX Cubeddu NA Zarate CB Rosales DW Zschaeck 1982 Prazosin and propranolol in preoperative management of pheochromocytoma Clin. Pharmacol. Ther. 32 2 156 160 1:STN:280:DyaL383jsVGmtQ%3D%3D 10.1038/clpt.1982.141 7094503
11. VA Alabaster MJ Davey 1986 The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology Br. J. Clin. Pharmacol. 21 Suppl. 1 9S 17S 1:CAS:528:DyaL28XktVSns7g%3D 2871857
12. HL Elliott PA Meredith J Vincent JL Reid 1986 Clinical pharmacological studies with doxazosin Br. J. Clin. Pharmacol. 21 Suppl. 1 27S 31S 1:CAS:528:DyaL28XktVSjsbc%3D 2871854
13. AN van der Horst-Schrivers MN Kerstens BH Wolffenbuttel 2006 Preoperative pharmacological management of phaeochromcytoma Neth. J. Med. 64 8 290 295 16990692
14. M Brauckhoff O Gimm H Dralle 2004 Preoperative and surgical therapy in sporadic and familial pheochromocytoma Front Horm Res. 31 121 144 10.1159/000074661 14674308